Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Amifostine during induction remission to reduce complications in autologous HSCT for lymphoma
ChiCTR-IPR-17013115Phase 4Not yet recruiting
- Sponsor
- Huadong Hospital, Fudan University
- Start
- Feb 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of amifostine in lymphoma (2 arms), sponsored by Huadong Hospital, Fudan University. Primary endpoints: Blood routine test, Biochemistry indices and 2 more. Planned start Feb 2018; status: not yet recruiting.
02
Drugs
amifostine
03
Conditions
lymphoma
Beyond the preview
Go deeper on ChiCTR-IPR-17013115.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-IPR-17013115.